Xeriant, Inc.: Form 10-Q for the period ended Mar 31, 2025
Filed with the SEC on May 15, 2025 and accepted by EDGAR at May 15, 2025, 12:24 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2025-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Research and development | 3 months2025-01-01 to 2025-03-31 | $30.2k | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2024-07-01 to 2025-03-31 | $56.8k | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2025-01-01 to 2025-03-31 | −$458.9k | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2024-07-01 to 2025-03-31 | −$1.2m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2025-01-01 to 2025-03-31 | $66.2k | us-gaap:InterestExpense |
| Interest expense | 9 months2024-07-01 to 2025-03-31 | $179.1k | us-gaap:InterestExpense |
| Income tax | 3 months2025-01-01 to 2025-03-31 | $0 | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2024-07-01 to 2025-03-31 | $0 | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2025-01-01 to 2025-03-31 | −$527.7k | us-gaap:NetIncomeLoss |
| Net income | 9 months2024-07-01 to 2025-03-31 | −$1.3m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2025-01-01 to 2025-03-31 | $0.00 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2024-07-01 to 2025-03-31 | $0.00 | us-gaap:EarningsPerShareDiluted |
| Diluted shares (weighted) | 3 months2025-01-01 to 2025-03-31 | 654,797,086 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2024-07-01 to 2025-03-31 | 599,035,774 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2024-07-01 to 2025-03-31 | −$1.1m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Current assets | At period end2025-03-31 | $61.9k | us-gaap:AssetsCurrent |
| Total assets | At period end2025-03-31 | $73.2k | us-gaap:Assets |
| Current liabilities | At period end2025-03-31 | $8.7m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2025-03-31 | $8.7m | us-gaap:Liabilities |
| Shareholders' equity | At period end2025-03-31 | −$5.7m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001477932-25-003761. Last ingested by Listed: Oct 24, 2026, 15:08 ET. Listed shows no prices and gives no investment advice.